Nearly 4 years since the first messenger RNA (mRNA) COVID-19 vaccines were developed, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is evolving more quickly than tailored ...

The White House hosted a forum on the next generation of COVID-19 vaccines as pharmaceutical companies plan on releasing updated shots this fall. The forum was held on Tuesday as COVID-19 cases grow ...

Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ...

CAMBRIDGE, Mass. — Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12-64 with at ...

In November 2024, the Data Safety Monitoring Board (DSMB) for the ongoing Phase 2 clinical trial of GEO-CM04S1 as a booster vaccine for patients with CLL conducted an interim data review of the study.

SILVER SPRING, Md. — The Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since ...

In the early days, the virus posed a graver threat to people and the health care system, Trump embraced lockdowns he now ...